6MW3511 in Patients With Advanced Solid Tumor
NCT05524194
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
272
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumors
Interventions
DRUG:
Intravenous Infusion
Sponsor
Mabwell (Shanghai) Bioscience Co., Ltd.